The 2025 VDW will comprehensively explore the biological actions of vitamin D in bone, kidney, pregnancy and the immune system. Outcomes of large scale, long term supplementation trials, including VDAART, VITAL and GRAVITD, will be presented by their lead investigators. Additional sessions will highlight the potential impacts of vitamin D status on cancer, neurophysiology and cardiometabolic disease.   

Margherita Cantorna, Pennsylvania State University, USA
JoAnn Manson, Harvard Medical School, USA
Patricio Artusa, McGill University, Canada
Scott T. Weiss, Harvard Medical School, USA
Gilles Laverny, IGBMC, France 
Custodia Garcia, King Juan Carlos University, Spain
Anna Louise Vestergaard, Aarhus University, Denmark 
Carol Wagner, Medical University of South Carolina, USA
Carmen Reynolds, Mayo Clinic, USA  
Augusto A Litonjua, University of Rochester Medical Center, USA
Chris Kovacs, Memorial University, Canada
Jim Fleet, University of Texas, USA 
Inez Schoenmakers, University of East Anglia, UK
Dylan Thompson, University of Bath, UK   
Anastassios Pittas, Tufts University, USA
Carlos Bernal-Mizrahi, Washington University, USA
Ana Lucia Rodrigues, Universidade Federal de Santa Catarina, Brazil 
Sha Sha, DKFZ German Cancer Research Center, Germany  
Glenville Jones, Queen’s University, Canada  
Annemieke Heijboer, VU University Medical Center,  The Netherlands
Ken White, Indiana University, USA   
Mark Meyer, University of Wisconsin-Madison, USA
Myles Wolf, Cornell University, USA